Patent · US Active

Treatment of NAFLD and NASH

US10722483B2 · kind B2 · utility

1Cited by
21References
19Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMay 23, 2019
Grant dateJul 28, 2020
Priority date—
Expiry dateMay 23, 2039

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P29/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Treatment of NAFLD and NASH by therapy with MBX-8025 or an MBX-8025 salt.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.